174 related articles for article (PubMed ID: 37253016)
1. Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis.
Li W; Kou J; Zhang Z; Li H; Li L; Du W
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2217869120. PubMed ID: 37253016
[TBL] [Abstract][Full Text] [Related]
2. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
Jeong SM; Lee A; Lee J; Haigis MC
J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence.
Jiang P; Du W; Mancuso A; Wellen KE; Yang X
Nature; 2013 Jan; 493(7434):689-93. PubMed ID: 23334421
[TBL] [Abstract][Full Text] [Related]
4. SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice.
Zhao X; Petrashen AP; Sanders JA; Peterson AL; Sedivy JM
Aging Cell; 2019 Jun; 18(3):e12947. PubMed ID: 30909319
[TBL] [Abstract][Full Text] [Related]
5. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
6. MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis.
Nguyen HV; Vandenberg CJ; Robati MR; Ng AP; Cory S
Cell Death Differ; 2023 Apr; 30(4):1018-1032. PubMed ID: 36755068
[TBL] [Abstract][Full Text] [Related]
7. The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.
Miyazaki M; Miyazaki K; Chen S; Chandra V; Wagatsuma K; Agata Y; Rodewald HR; Saito R; Chang AN; Varki N; Kawamoto H; Murre C
Genes Dev; 2015 Feb; 29(4):409-25. PubMed ID: 25691468
[TBL] [Abstract][Full Text] [Related]
8. Antigen Complexed with a TLR9 Agonist Bolsters c-Myc and mTORC1 Activity in Germinal Center B Lymphocytes.
Wigton EJ; DeFranco AL; Ansel KM
Immunohorizons; 2019 Aug; 3(8):389-401. PubMed ID: 31427364
[TBL] [Abstract][Full Text] [Related]
9. Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.
Shortt J; Martin BP; Newbold A; Hannan KM; Devlin JR; Baker AJ; Ralli R; Cullinane C; Schmitt CA; Reimann M; Hall MN; Wall M; Hannan RD; Pearson RB; McArthur GA; Johnstone RW
Blood; 2013 Apr; 121(15):2964-74. PubMed ID: 23403624
[TBL] [Abstract][Full Text] [Related]
10. T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.
Daniel CJ; Pelz C; Wang X; Munks MW; Ko A; Murugan D; Byers SA; Juarez E; Taylor KL; Fan G; Coussens LM; Link JM; Sears RC
Mol Cancer Res; 2022 Jul; 20(7):1151-1165. PubMed ID: 35380701
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
[TBL] [Abstract][Full Text] [Related]
12. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma.
Hartleben G; Müller C; Krämer A; Schimmel H; Zidek LM; Dornblut C; Winkler R; Eichwald S; Kortman G; Kosan C; Kluiver J; Petersen I; van den Berg A; Wang ZQ; Calkhoven CF
EMBO J; 2018 Nov; 37(21):. PubMed ID: 30237309
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of malic enzyme 2 suppresses lung tumor growth, induces differentiation and impacts PI3K/AKT signaling.
Ren JG; Seth P; Clish CB; Lorkiewicz PK; Higashi RM; Lane AN; Fan TW; Sukhatme VP
Sci Rep; 2014 Jun; 4():5414. PubMed ID: 24957098
[TBL] [Abstract][Full Text] [Related]
15. FoxO3 suppresses Myc-driven lymphomagenesis.
Vandenberg CJ; Motoyama N; Cory S
Cell Death Dis; 2016 Jan; 6(1):e2046. PubMed ID: 26764572
[TBL] [Abstract][Full Text] [Related]
16. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.
White MA; Lin C; Rajapakshe K; Dong J; Shi Y; Tsouko E; Mukhopadhyay R; Jasso D; Dawood W; Coarfa C; Frigo DE
Mol Cancer Res; 2017 Aug; 15(8):1017-1028. PubMed ID: 28507054
[TBL] [Abstract][Full Text] [Related]
17. IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.
Petrenko O; Li J; Cimica V; Mena-Taboada P; Shin HY; D'Amico S; Reich NC
PLoS One; 2021; 16(3):e0247394. PubMed ID: 33651821
[TBL] [Abstract][Full Text] [Related]
18. Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.
Zeng H; Yu M; Tan H; Li Y; Su W; Shi H; Dhungana Y; Guy C; Neale G; Cloer C; Peng J; Wang D; Chi H
Sci Adv; 2018 Jan; 4(1):eaar5701. PubMed ID: 29399633
[TBL] [Abstract][Full Text] [Related]
19. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis.
Potts MA; Mizutani S; Garnham AL; Li Wai Suen CSN; Kueh AJ; Tai L; Pal M; Strasser A; Herold MJ
Cell Death Differ; 2023 Jun; 30(6):1447-1456. PubMed ID: 36894688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
